Evidence map›Paper›PMID 27638615›Full record

ArticleJournal of neuroscience research2016

Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.

Giuseppe Scesa, Ana Lis Moyano, Ernesto R Bongarzone, Maria I Givogri

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giuseppe ScesaDepartment of Anatomy and Cell Biology, College of Medicine. University of Illinois at Chicago, Chicago, Illinois.
Ana Lis MoyanoDepartment of Anatomy and Cell Biology, College of Medicine. University of Illinois at Chicago, Chicago, Illinois.
Ernesto R BongarzoneDepartment of Anatomy and Cell Biology, College of Medicine. University of Illinois at Chicago, Chicago, Illinois.
Maria I GivogriDepartment of Anatomy and Cell Biology, College of Medicine. University of Illinois at Chicago, Chicago, Illinois. mgivogri@uic.edu.
University of Illinois Chicago · US

Funding

Combined Neuroprotection and Metabolic Correction to Treat LeukodystrophiesR01NS065808 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONGARZONE, ERNESTO ROQUE · 2009 to 2018
$3.0M
Therapies to Stimulate RemyelinationR21NS087474 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONGARZONE, ERNESTO ROQUE · 2014 to 2015
$426k
NINDS NIH HHS R01 NS065808NINDS NIH HHS R21 NS087474
6 · The paper itself

Abstract

The discovery that most cells produce extracellular vesicles (EVs) and release them in the extracellular milieu has spurred the idea that these membranous cargoes spread pathogenic mechanisms. In the brain, EVs may have multifold and important physiological functions, from deregulating synaptic activity to promoting demyelination to changes in microglial activity. The finding that small EVs (exosomes) contain α-synuclein and β-amyloid, among other pathogenic proteins, is an example of this notion, underscoring their potential role in the brains of patients with Parkinson's and Alzheimer's diseases. Given that they are membranous vesicles, we speculate that EVs also have an intrinsic capacity to incorporate sphingolipids. In conditions under which these lipids are elevated to toxic levels, such as in Krabbe's disease and metachromatic leukodystrophy, EVs may contribute to spread disease from sick to healthy cells. In this essay, we discuss a working hypothesis that brain cells in sphingolipidoses clear some of the accumulated lipid material to attempt restoring cell homeostasis via EV secretion. We hypothesize that secreted sphingolipid-loaded EVs shuttle pathogenic lipids to cells that are not intrinsically affected, contributing to establishing non-cell-autonomous defects. © 2016 Wiley Periodicals, Inc.

Indexed as

AnimalsBiological TransportBrainCell CommunicationExtracellular VesiclesHumansModels, BiologicalSphingolipidosesSphingolipidsSphingolipidsautophagyexosomesextracellular vesicleslysosomessphingolipidosistauα-synucleinβ-amyloid

Identifiers

PMID27638615
PMCPMC5027965
OpenAlexW2519068928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.